Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracerebral granulocytic sarcoma.

Margaret Alvarez1

  • 1University of Chicago Medical Center, Chicago, IL, USA. apoychubby@hotmail.com

The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
|October 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Craniopharyngiomas.

The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses·2006
Same author

Spinal epidural abscess-from onset to rehabilitation: case study.

The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses·2005
See all related articles

Intracerebral granulocytic sarcoma (IGS) is a rare brain tumor complication of leukemia. Due to chemotherapy limitations, IGS incidence is rising, necessitating further research into optimal treatments.

Area of Science:

  • Hematology
  • Neurology
  • Oncology

Background:

  • Granulocytic sarcomas (chloromas) are extramedullary tumors of myeloid origin.
  • They are frequently associated with myelogenous leukemia and myeloproliferative disorders.

Observation:

  • Intracerebral granulocytic sarcoma (IGS) is a rare form of leukemia involvement in the central nervous system.
  • Clinical presentation varies based on affected brain structures.
  • Magnetic resonance imaging (MRI) with gadolinium and tissue biopsy are crucial for diagnosis.

Findings:

  • Optimal treatment for IGS remains unclear due to limited literature.
  • The incidence of IGS is projected to increase as more leukemia patients achieve remission.
  • The blood-brain barrier limits the efficacy of systemic chemotherapy, making the brain a sanctuary site for leukemia recurrence.

Related Experiment Videos

Implications:

  • Further research is needed to establish optimal treatment protocols for IGS.
  • Nurses play a critical role in patient education and support, particularly concerning neurocognitive adjustments.
  • Understanding IGS is vital for managing leukemia patients with potential central nervous system involvement.